Answer
Oct 01, 2025 - 05:54 AM
NUCALA (mepolizumab) is a monoclonal antibody used to treat conditions like severe eosinophilic asthma and certain other eosinophilic conditions. Weight gain is not commonly reported as a side effect of NUCALA in clinical trials or product information. However, individual reactions to medication can vary, so it’s important to consult a healthcare provider if you have concerns about weight changes while using NUCALA.
